Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet thromboembolism

C M Kessler1, S R Hanson

  • 1Department of Neurology, Ernst-Moritz-Arndt-University, Greifswald, Germany.

European Journal of Clinical Investigation
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pain in haemophilia: are we listening?

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Methodologies for data collection in congenital haemophilia with inhibitors (CHwI): critical assessment of the literature and lessons learned from recombinant factor VIIa.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Lenalidomide as a novel therapy for gastrointestinal angiodysplasia in von Willebrand disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Efficacy and safety of Nuwiq<sup>®</sup> (human-cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Acquired haemophilia in cancer: A systematic and critical literature review.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

Pinpointing clinical phenotypes - Is there evidence to support the use of a simple scoring system to define a milder bleeding phenotype in severe haemophilia A?

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same journal

Pacemaker Status and 5-Year Mortality After TAVI: A Sex-Specific Analysis.

European journal of clinical investigation·2026
Same journal

Causal Effects of Time-Varying Treatments: The G-Formula.

European journal of clinical investigation·2026
Same journal

Improving Scientific Research: Renegotiated Principles of Science, Proposals, Failures, and Successes.

European journal of clinical investigation·2026
Same journal

Beta-Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta-Analysis With Trial Sequential Analysis.

European journal of clinical investigation·2026
Same journal

Prognostic Role of Serum Albumin Levels in Elderly Patients With Non-Valvular Atrial Fibrillation.

European journal of clinical investigation·2026
Same journal

Circulating Human Epididymis Protein 4 Predicts 10-Year Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Artery Disease.

European journal of clinical investigation·2026
See all related articles

Platelet inhibitors targeting the GP IIb/IIIa receptor prevent emboli in brain circulation. Thrombin inhibitors like hirudin are also effective, with emboli retention varying by vascular bed.

Area of Science:

  • Cardiovascular Research
  • Hematology
  • Neuroscience

Background:

  • Platelet aggregation and thrombosis are key contributors to ischemic events, particularly in the brain.
  • Existing antiplatelet therapies like aspirin have limitations, necessitating exploration of alternative pathways.
  • Thrombin plays a critical role in platelet activation and thrombus formation in vivo.

Purpose of the Study:

  • To investigate the efficacy of a specific peptide inhibitor of the GP IIb/IIIa receptor in preventing platelet aggregate retention in cerebral circulation.
  • To evaluate the effectiveness of direct thrombin inhibitors (hirudin) and activated protein C in preventing platelet-dependent thrombus formation.
  • To determine how vascular bed characteristics influence the retention of platelet emboli.

Main Methods:

Related Experiment Videos

  • Utilized a non-human primate experimental model of platelet embolization.
  • Administered a specific peptide inhibitor targeting the GP IIb/IIIa receptor, which blocks fibrinogen binding.
  • Assessed the impact of leech-derived hirudin and activated protein C on thrombin-mediated platelet activation.
  • Compared the retention of platelet emboli in cerebral microcirculation versus the lower limb vasculature (femoral artery).

Main Results:

  • A specific peptide inhibitor blocking the GP IIb/IIIa receptor effectively prevented the retention of embolized platelet aggregates in the cerebral circulation.
  • Leech-derived hirudin and activated protein C demonstrated significant efficacy in preventing platelet-dependent thrombus formation.
  • Platelet emboli were cleared rapidly from the brain's microcirculation.
  • Platelet embolization into the lower limb resulted in significantly longer retention of embolized material compared to the brain.

Conclusions:

  • Targeting the GP IIb/IIIa receptor is a viable strategy to prevent cerebral ischaemia caused by platelet emboli.
  • Thrombin inhibition is effective in mitigating platelet-dependent thrombosis.
  • Vascular bed properties, potentially influenced by local vasodilators like PGI2 or EDRF, significantly affect embolus clearance rates.